Literature DB >> 14657354

TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest.

Neil A Bhowmick1, Mayshan Ghiassi, Mary Aakre, Kimberly Brown, Vikas Singh, Harold L Moses.   

Abstract

The ability of the transforming growth factor beta (TGF-beta) signaling pathways to inhibit proliferation of most cells while stimulating proliferation of others remains a conundrum. In this article, we report that the absence of RhoA and p160ROCK activity in fibroblastic NIH 3T3 cells and its presence in epithelial NMuMG cells can at least partially explain the difference in the TGF-beta growth response. Further, evidence is presented for TGF-beta-stimulated p160ROCK translocation to the nucleus and inhibitory phosphorylation of the cyclin-dependent kinase-activating phosphatase, Cdc25A. The resultant suppression of Cdk2 activity contributes to G1/S inhibition in NMuMG cells. These data provide evidence that signaling through RhoA and p160ROCK is important in TGF-beta inhibition of cell proliferation and links signaling components for epithelial transdifferentiation with regulation of cell-cycle progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657354      PMCID: PMC307605          DOI: 10.1073/pnas.2536483100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Accumulation of GTP-bound RhoA during cytokinesis and a critical role of ECT2 in this accumulation.

Authors:  K Kimura; T Tsuji; Y Takada; T Miki; S Narumiya
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

Review 2.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation.

Authors:  R Bernardi; D A Liebermann; B Hoffman
Journal:  Oncogene       Date:  2000-05-11       Impact factor: 9.867

4.  TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event.

Authors:  R A Clark; G A McCoy; J M Folkvord; J M McPherson
Journal:  J Cell Physiol       Date:  1997-01       Impact factor: 6.384

Review 5.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

Review 6.  Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.

Authors:  O Kranenburg; W H Moolenaar
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

Review 7.  Mammalian G1- and S-phase checkpoints in response to DNA damage.

Authors:  J Bartek; J Lukas
Journal:  Curr Opin Cell Biol       Date:  2001-12       Impact factor: 8.382

8.  The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.

Authors:  J Falck; N Mailand; R G Syljuåsen; J Bartek; J Lukas
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

Review 9.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

10.  Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior.

Authors:  E E Sander; J P ten Klooster; S van Delft; R A van der Kammen; J G Collard
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  41 in total

1.  Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicle.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

2.  Expanding the available assays: adapting and validating In-Cell Westerns in microfluidic devices for cell-based assays.

Authors:  Amy L Paguirigan; John P Puccinelli; Xiaojing Su; David J Beebe
Journal:  Assay Drug Dev Technol       Date:  2010-07-26       Impact factor: 1.738

3.  Transforming growth factor beta facilitates beta-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner.

Authors:  Dipankar Ray; Yasuhisa Terao; Dipali Nimbalkar; Li-Hao Chu; Maddalena Donzelli; Tateki Tsutsui; Xianghong Zou; Asish K Ghosh; John Varga; Giulio F Draetta; Hiroaki Kiyokawa
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  Long-term treatment with TGFbeta1 impairs mechanotransduction in bovine aortic endothelial cells.

Authors:  M Watanabe; M Oike; Y Ohta; Y Ito
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

5.  A keratinocyte hypermotility/growth-arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence.

Authors:  Easwar Natarajan; John D Omobono; Zongyou Guo; Susan Hopkinson; Alexander J F Lazar; Thomas Brenn; Jonathan C Jones; James G Rheinwald
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

6.  RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells.

Authors:  Benjamin Chaigne-Delalande; Lynda Deuve; Edith Reuzeau; Caroline Basoni; David Lafarge; Christine Varon; Florence Tatin; Guerric Anies; Richard Garand; Ijsbrand Kramer; Elisabeth Génot
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

7.  CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Authors:  C Dozier; L Mazzolini; C Cénac; C Froment; O Burlet-Schiltz; A Besson; S Manenti
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

Review 8.  Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspects.

Authors:  Ian Toma; Timothy A McCaffrey
Journal:  Cell Tissue Res       Date:  2011-05-31       Impact factor: 5.249

Review 9.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

10.  Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA.

Authors:  Todd A Townsend; Jeffrey L Wrana; George E Davis; Joey V Barnett
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.